Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Overview

Basic information

Litigation

Active legal matters

Material Events

8-K disclosures

SEC Filings

Key regulatory docs

Insider Transactions

Ownership changes

Aldeyra Therapeutics, Inc. (ALDX) Class Action Lawsuit (March 2026)

In Litigation

1:26cv11510 • March 30, 2026

Class Period Start

November 3, 2023

Class Period End

March 16, 2026

PSLRA Deadline

May 29, 2026

Case Allegations

10b5

Statutes of Repose

Nov 3, 2026

Country

United States

Court

Federal Court

Docket History

Oct 9, 2026

First Amended Complaint

A new complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Aug 10, 2026

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Mar 30, 2026

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in Aldeyra Therapeutics, Inc..

TOP